Dog Immune Thrombocytopenia: Recognition and Care

Immune-mediated thrombocytopenia (IMT) is a serious autoimmune condition in dogs where the immune system destroys platelets, causing dangerous bleeding disorders requiring prompt veterinary intervention.

Key Facts

IMT is among the most common acquired bleeding disorders in dogs, with female dogs slightly overrepresented
The immune system produces antibodies that attack platelets, causing platelet counts to fall dramatically
Signs include pinpoint skin haemorrhages, bruising, bleeding gums, blood in urine or faeces, and lethargy
Cocker Spaniels, Poodles, and Old English Sheepdogs have elevated breed prevalence
Treatment typically involves immunosuppressive doses of corticosteroids such as prednisolone
Most dogs respond well to treatment though relapses occur in around 30 percent of cases

Welfare Considerations

IMT causes significant welfare suffering through the risk of life-threatening haemorrhage, the discomfort of bruising and mucosal bleeding, and the side effects of high-dose corticosteroid therapy including increased thirst, hunger, and urination. Dogs in the acute phase may be lethargic and distressed. Early recognition is critical to prevent spontaneous internal bleeding. Long-term welfare management involves careful tapering of immunosuppression while monitoring for relapse through regular blood counts, minimising both disease and treatment burdens.

What You Can Do

Learn to recognise petechiae (pinpoint red dots on skin or gums) as an emergency sign requiring same-day veterinary assessment
Follow veterinary taper schedules for immunosuppressive drugs precisely — stopping early risks relapse
Schedule regular complete blood count monitoring as recommended, typically every 2-4 weeks during treatment
Avoid medications that impair platelet function such as aspirin unless specifically directed by your vet